BERTI, EMILIO
BERTI, EMILIO
Universita' degli Studi di MILANO
Primary cutaneous, epidermotropic mycosis fungoides-like presentation: critical appraisal and description of two novel cases, broadening the spectrum of ALK+ T-cell lymphoma
2024 G.A. Croci, L. Appio, C. Cecchetti, S. Tabano, S. Alberti-Violetti, E. Berti, D. Rahal, F. Cavallaro, F. Onida, D. Tomasini, E. Todisco
The unexpected guest: Cytotoxic, pseudolymphoma-like reaction at the site of primary cutaneous follicle centre B-cell lymphoma in a patient receiving secukinumab for psoriasis
2024 C. Pescia, G. Pini, S. Tabano, E. Berti, S. Alberti Violetti, G.A. Croci
Clinicopathological definition, management and prognostic value of mogamulizumab‐associated rash and other cutaneous events: A systematic review
2024 G. Avallone, G. Roccuzzo, A. Pileri, C. Agostinelli, C.A. Maronese, C. Aquino, G. Tavoletti, F. Onida, P. Fava, S. Ribero, A.V. Marzano, E. Berti, P. Quaglino, S. Alberti‐violetti
Mental health in patients affected by atopic dermatitis: which effects of treatment with dupilumab?
2024 S. Ferrucci, S. Tavecchio, G. Nicolini, L. Angileri, A. Ceresa, G. Del Tordello, E. Berti, A. Marzano, M. Buoli
Whole-exome sequencing is feasible on a fresh-frozen skin sample of intravascular large B cell lymphoma
2024 F. Bagnoli, G. Pini, B. Ziccheddu, A. Bonometti, S. Alberti-Violetti, L. Venegoni, G. Isimbaldi, M.C. Da Vià, A. Ferrari, L. Baldini, A. Neri, F. Onida, N. Bolli, E. Berti
Which Factors Are Associated with Persistence of Depressive and Anxiety Symptoms in Patients Affected by Atopic Dermatitis despite 2-Year Treatment with Dupilumab?
2024 S. Ferrucci, S. Tavecchio, A. Ceresa, L. Angileri, E. Berti, A. Marzano, M. Buoli
SARS-CoV-2 Detection by Digital Polymerase Chain Reaction and Immunohistochemistry in Skin Biopsies from 52 Patients with Different COVID-19-Associated Cutaneous Phenotypes
2023 A.V. Marzano, C. Moltrasio, G. Genovese, M. De Andrea, V. Caneparo, P. Vezzoli, D. Morotti, P. Sena, M. Venturini, S. Battocchio, V. Caputo, N. Rizzo, C.A. Maronese, L. Venegoni, F.L. Boggio, F. Rongioletti, P. Calzavara-Pinton, E. Berti
The Relevant Oral Burden of Patients with Hidradenitis Suppurativa
2023 G. Damiani, P.P. Poli, A. Pacifico, E. Rosi, G. Allocca, E. Berti, S. Taschieri, M. Tumedei, M. Del Fabbro, S.R. Mercuri, M. Bindi, L. Francetti, A. Buja, F. Prignano, C. Maiorana
T follicular helper phenotype mycosis fungoides associated with acanthosis nigricans
2023 C.B. Spigariolo, E. Berti, A. Cerri, L. Venegoni, G. Croci, S.A. Violetti
Unmet Clinical Needs and Management Recommendations for Blastic Plasmacytoid Dendritic Cell Neoplasm: A Consensus-based Position Paper From an Ad Hoc International Expert Panel
2023 L. Pagano, P.L. Zinzani, S. Pileri, P. Quaglino, B. Cuglievan, E. Berti, N. Pemmaraju, F. Onida, R. Willemze, A. Orfao, G. Barosi
Primary cutaneous epidermotropic, cytotoxic, ALK+ T-cell lymphoma: observation of a novel case and review of the literature point at a discrete pattern of disease, with response to target therapy
2023 G.A. Croci, E. Berti
Type D lymphomatoid papulosis with pityriasis lichenoides et varioliformis acuta-like features in a child with parvovirus infection: a controversial diagnosis in the spectrum of lymphoid proliferations: case report and literature review
2022 V. Calcaterra, R. Cavalli, G.A. Croci, L. Fiori, A. Fabiano, L. Lunardon, M.A. Avanzini, E. Berti, G. Zuccotti
Topical tacrolimus during systemic therapy for severe atopic dermatitis in the clinical practice
2022 S.M. Ferrucci, L. Angileri, A.V. Marzano, E. Berti, S. Tavecchio
Real-world data on primary cutaneous lymphoproliferative disorders following SARS-CoV-2 vaccination: A multicentre experience from tertiary referral hospitals
2022 G. Avallone, C.A. Maronese, C. Conforti, P. Fava, L. Gargiulo, A.V. Marzano, C. Massone, L. Mastorino, A. Paradisi, A. Pileri, P. Quaglino, N. Rizzo, S. Ribero, G. Roccuzzo, G. Tavoletti, C.A. Vignoli, I. Zalaudek, E. Berti, S. Alberti-Violetti
The role of radiotherapy in the management of Cutaneous Squamous Cell Carcinoma: a retrospective study on 92 cases
2022 P. Bortoluzzi, R. Brambilla, E. Berti, A.V. Marzano, R. Piccinno
Case report: A case of anti-laminin 332 mucous membrane pemphigoid associated with severe pharyngolaryngeal involvement
2022 E. Quattri, M. Zussino, W. Lauro, E. Berti, A.V. Marzano, G. Genovese
Deregulation of JAK2 signaling underlies primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma
2022 A.N. Bastidas Torres, D. Cats, J.J. Out-Luiting, D. Fanoni, H. Mei, L. Venegoni, R. Willemze, M.H. Vermeer, E. Berti, C.P. Tensen
Cutaneous B-cell lymphomas: Update on diagnosis, risk-stratification, and management
2022 P. Fava, G. Roccuzzo, S. Alberti-Violetti, V. Grandi, A. Pileri, N. Pimpinelli, E. Berti, P. Quaglino
An expert consensus report on mycosis fungoides in Italy: Epidemiological impact and diagnostic-therapeutic pathway
2021 S. Alberti Violetti, M. Alaibac, M. Ardigò, A. Baldo, N. Di Meo, C. Massone, F. Onida, G. Simontacchi, I. Zalaudek, N. Pimpinelli, P. Quaglino, E. Berti
The clinical spectrum of COVID-19-associated cutaneous manifestations: an Italian multicentre study of 200 adult patients
2021 A.V. Marzano, G. Genovese, C. Moltrasio, V. Gaspari, P. Vezzoli, V. Maione, C. Misciali, P. Sena, A. Patrizi, A. Offidani, P. Quaglino, R. Arco, M. Caproni, M. Rovesti, G. Bordin, S. Recalcati, C. Potenza, C. Guarneri, G. Fabbrocini, C. Tomasini, M. Sorci, M. Lombardo, P. Gisondi, A. Conti, G. Casazza, K. Peris, P. Calzavara-Pinton, E. Berti